Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 06, 2020

SELL
$4.84 - $8.02 $600 - $994
-124 Closed
0 $0
Q4 2019

May 11, 2020

SELL
$6.14 - $9.3 $1,228 - $1,860
-200 Reduced 61.73%
124 $0
Q3 2019

May 08, 2020

BUY
$9.05 - $16.02 $1,357 - $2,403
150 Added 86.21%
324 $2,000
Q2 2019

May 08, 2020

SELL
$13.58 - $18.61 $882 - $1,209
-65 Reduced 27.2%
174 $2,000
Q1 2019

May 11, 2020

BUY
$11.31 - $23.7 $836 - $1,753
74 Added 44.85%
239 $4,000
Q4 2018

May 07, 2020

SELL
$6.8 - $12.88 $680 - $1,288
-100 Reduced 37.74%
165 $1,000
Q3 2018

May 07, 2020

BUY
$5.65 - $13.75 $1,130 - $2,750
200 Added 307.69%
265 $2,000
Q1 2018

May 07, 2020

BUY
$5.51 - $10.97 $358 - $713
65 New
65 $0

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $760M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Royal Fund Management, LLC Portfolio

Follow Royal Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Fund Management, LLC with notifications on news.